A Novel Non-Invasive Approach Based on Serum Ceruloplasmin for Identifying Non-Alcoholic Steatohepatitis Patients in the Non-Diabetic Population. This evidence concerns the gene CP and metabolic dysfunction-associated steatohepatitis.